<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Pharma News from PharmiWeb.com</title><link>http://www.pharmiweb.com</link><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/Pharmaceutical-News" /><description>Global news and press releases from the Pharmaceutical industry</description><language>en-gb</language><copyright>&amp;#169; 1998 - 2013 PharmiWeb Solutions - All Rights Reserved</copyright><lastBuildDate>Thu, 23 May 2013 18:00:00 PDT</lastBuildDate><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/Pharmaceutical-News" /><feedburner:info uri="pharmaceutical-news" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>Pharmaceutical-News</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item><title>Company Profile for AIBioTech</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/izNT5jQepws/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74913</guid><description>&lt;strong&gt;Company Profile for AIBioTech&lt;/strong&gt;&lt;br /&gt;AIBioTech is a comprehensive contract research organization which provides integrated research ...&lt;br /&gt;AIBioTech&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=izNT5jQepws:LeLPLjuMwto:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=izNT5jQepws:LeLPLjuMwto:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=izNT5jQepws:LeLPLjuMwto:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=izNT5jQepws:LeLPLjuMwto:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/izNT5jQepws" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74913</feedburner:origLink></item><item><title>Impax Laboratories to Present at the Deutsche Bank 38th Annual Health Care Conference</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/mzIkffToyNo/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74914</guid><description>&lt;strong&gt;Impax Laboratories to Present at the Deutsche Bank 38th Annual Health Care Conference&lt;/strong&gt;&lt;br /&gt;Impax Laboratories Inc.&lt;br /&gt;Impax Laboratories Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=mzIkffToyNo:pATbF_a_kVw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=mzIkffToyNo:pATbF_a_kVw:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=mzIkffToyNo:pATbF_a_kVw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=mzIkffToyNo:pATbF_a_kVw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/mzIkffToyNo" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74914</feedburner:origLink></item><item><title>Derma Sciences Appoints Medical Device Veteran Amy S. Paul to Its Board of Directors</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/m0gIOrE5Wvg/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74915</guid><description>&lt;strong&gt;Derma Sciences Appoints Medical Device Veteran Amy S. Paul to Its Board of Directors&lt;/strong&gt;&lt;br /&gt;Derma Sciences Inc.&lt;br /&gt;Derma Sciences Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=m0gIOrE5Wvg:6LJee2PsqxI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=m0gIOrE5Wvg:6LJee2PsqxI:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=m0gIOrE5Wvg:6LJee2PsqxI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=m0gIOrE5Wvg:6LJee2PsqxI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/m0gIOrE5Wvg" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74915</feedburner:origLink></item><item><title>Clinical Professionals London office move.</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/w7UTljwIC2w/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74911</guid><description>&lt;strong&gt;Clinical Professionals London office move.&lt;br /&gt;Clinical Professionals&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=w7UTljwIC2w:gOvWulTh8Qk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=w7UTljwIC2w:gOvWulTh8Qk:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=w7UTljwIC2w:gOvWulTh8Qk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=w7UTljwIC2w:gOvWulTh8Qk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/w7UTljwIC2w" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74911</feedburner:origLink></item><item><title>Microsoft software harnessed by OCSL’s acceSSOnce desktop solution to improve patient care at Luton and Dunstable University NHS Foundation Trust Hospital</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/OmXpu7BkRz8/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74910</guid><description>&lt;strong&gt;Microsoft software harnessed by OCSL’s acceSSOnce desktop solution to improve patient care at Luton and Dunstable University NHS Foundation...&lt;br /&gt;Luton and Dunstable NHS Foundation Trust Hospital&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OmXpu7BkRz8:Jj5vo-mdTFc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OmXpu7BkRz8:Jj5vo-mdTFc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OmXpu7BkRz8:Jj5vo-mdTFc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=OmXpu7BkRz8:Jj5vo-mdTFc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/OmXpu7BkRz8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74910</feedburner:origLink></item><item><title>ArQule to Report First Quarter 2013 Financial Results on May 8, 2013</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/rtSJ7Mwt4Fw/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74260</guid><description>&lt;strong&gt;ArQule to Report First Quarter 2013 Financial Results on May 8, 2013&lt;/strong&gt;&lt;br /&gt;ArQule Inc.&lt;br /&gt;ArQule Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=rtSJ7Mwt4Fw:wyjkQsE8XFk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=rtSJ7Mwt4Fw:wyjkQsE8XFk:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=rtSJ7Mwt4Fw:wyjkQsE8XFk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=rtSJ7Mwt4Fw:wyjkQsE8XFk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/rtSJ7Mwt4Fw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74260</feedburner:origLink></item><item><title>Study Demonstrates Significant Pain Reduction with DFINE STAR™ Tumor Ablation System in Spinal Metastases</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/AOaBmB5rzQU/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74261</guid><description>&lt;strong&gt;Study Demonstrates Significant Pain Reduction with DFINE STAR™ Tumor Ablation System in Spinal Metastases&lt;/strong&gt;&lt;br /&gt;DFINE Inc.&lt;br /&gt;DFINE Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=AOaBmB5rzQU:NnYw8ot7Vc4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=AOaBmB5rzQU:NnYw8ot7Vc4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=AOaBmB5rzQU:NnYw8ot7Vc4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=AOaBmB5rzQU:NnYw8ot7Vc4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/AOaBmB5rzQU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74261</feedburner:origLink></item><item><title>Lucigen Corporation and Research Corporation Technologies Announce Partnership and Launch of the Endotoxin free CleanColi™ Expression System</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/DQ73PYAf3hE/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74262</guid><description>&lt;strong&gt;Lucigen Corporation and Research Corporation Technologies Announce Partnership and Launch of the Endotoxin free CleanColi™ Expression Syste...&lt;br /&gt;Lucigen Corporation and Research Corporation Technologies&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DQ73PYAf3hE:Kv-2REAhmq4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DQ73PYAf3hE:Kv-2REAhmq4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DQ73PYAf3hE:Kv-2REAhmq4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=DQ73PYAf3hE:Kv-2REAhmq4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/DQ73PYAf3hE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74262</feedburner:origLink></item><item><title>Fluidigm to Develop and Supply a Custom High-throughput Prep System for HLA Typing</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/xRMnIwhzT6k/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74263</guid><description>&lt;strong&gt;Fluidigm to Develop and Supply a Custom High-throughput Prep System for HLA Typing&lt;/strong&gt;&lt;br /&gt;Fluidigm (www.fluidigm.&lt;br /&gt;Fluidigm Corporation&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=xRMnIwhzT6k:cq-77cBMr0E:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=xRMnIwhzT6k:cq-77cBMr0E:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=xRMnIwhzT6k:cq-77cBMr0E:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=xRMnIwhzT6k:cq-77cBMr0E:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/xRMnIwhzT6k" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74263</feedburner:origLink></item><item><title>Medgenics Announces Results of 2013 Annual Meeting of Stockholders</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/DURx-dV2HV8/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74264</guid><description>&lt;strong&gt;Medgenics Announces Results of 2013 Annual Meeting of Stockholders&lt;/strong&gt;&lt;br /&gt;Medgenics Inc.&lt;br /&gt;Medgenics Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DURx-dV2HV8:d4AxK8Qb9ZQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DURx-dV2HV8:d4AxK8Qb9ZQ:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=DURx-dV2HV8:d4AxK8Qb9ZQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=DURx-dV2HV8:d4AxK8Qb9ZQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/DURx-dV2HV8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74264</feedburner:origLink></item><item><title>David Sourdive, Vice President of Corporate Development at Cellectis, has been appointed by French Foreign Trade Minister Nicole Bricq to boost France’s export performance in the health sector</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/ldDuJ5laS1U/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74265</guid><description>&lt;strong&gt;David Sourdive, Vice President of Corporate Development at Cellectis, has been appointed by French Foreign Trade Minister Nicole Bricq to b...&lt;br /&gt;Cellectis&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ldDuJ5laS1U:98JmPMkkbWc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ldDuJ5laS1U:98JmPMkkbWc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ldDuJ5laS1U:98JmPMkkbWc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=ldDuJ5laS1U:98JmPMkkbWc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/ldDuJ5laS1U" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74265</feedburner:origLink></item><item><title>MindChild Medical, Inc. To Present the MERIDIAN™ Non-Invasive Fetal Heart Rate Monitor at the 61st Annual Meeting for the American College of Obstetricians and Gynecologists (ACOG) to be Held May 4-8, 2013 in New Orleans, LA</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/7OSqHsZqVTs/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74266</guid><description>&lt;strong&gt;MindChild Medical, Inc.&lt;br /&gt;MindChild Medical Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=7OSqHsZqVTs:6myhBET_xFQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=7OSqHsZqVTs:6myhBET_xFQ:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=7OSqHsZqVTs:6myhBET_xFQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=7OSqHsZqVTs:6myhBET_xFQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/7OSqHsZqVTs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74266</feedburner:origLink></item><item><title>Novella Clinical Expands West Coast Business Development Team</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/IYaXUrDHua4/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74267</guid><description>&lt;strong&gt;Novella Clinical Expands West Coast Business Development Team&lt;/strong&gt;&lt;br /&gt;Novella Clinical a full service clinical research organization ...&lt;br /&gt;Novella Clinical Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=IYaXUrDHua4:zO983LgpBg4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=IYaXUrDHua4:zO983LgpBg4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=IYaXUrDHua4:zO983LgpBg4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=IYaXUrDHua4:zO983LgpBg4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/IYaXUrDHua4" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74267</feedburner:origLink></item><item><title>California health system Joins the Premier healthcare alliance to Improve Care Quality and Costs</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/d0zwlR70ids/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74268</guid><description>&lt;strong&gt;California health system Joins the Premier healthcare alliance to Improve Care Quality and Costs&lt;/strong&gt;&lt;br /&gt;Community Medical Centers ha...&lt;br /&gt;Premier healthcare alliance&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=d0zwlR70ids:qN0_jdQxzgQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=d0zwlR70ids:qN0_jdQxzgQ:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=d0zwlR70ids:qN0_jdQxzgQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=d0zwlR70ids:qN0_jdQxzgQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/d0zwlR70ids" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74268</feedburner:origLink></item><item><title>Rite Aid Returns to Entertainment Industry Foundation Revlon Run/Walk For Women as Platinum Sponsor</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/hCfDB_w5ucY/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74269</guid><description>&lt;strong&gt;Rite Aid Returns to Entertainment Industry Foundation Revlon Run/Walk For Women as Platinum Sponsor&lt;/strong&gt;&lt;br /&gt;Rite Aid (NYSE: RAD) is p...&lt;br /&gt;Rite Aid Corporation&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=hCfDB_w5ucY:5OcnHTGp-yA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=hCfDB_w5ucY:5OcnHTGp-yA:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=hCfDB_w5ucY:5OcnHTGp-yA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=hCfDB_w5ucY:5OcnHTGp-yA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/hCfDB_w5ucY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74269</feedburner:origLink></item><item><title>Transgenomic to Hold First Quarter Financial Results Conference Call on May 8, 2013</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/ClyB_OXYG5c/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74270</guid><description>&lt;strong&gt;Transgenomic to Hold First Quarter Financial Results Conference Call on May 8, 2013&lt;/strong&gt;&lt;br /&gt;Transgenomic Inc.&lt;br /&gt;Transgenomic Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ClyB_OXYG5c:mIabjZIKPEg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ClyB_OXYG5c:mIabjZIKPEg:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ClyB_OXYG5c:mIabjZIKPEg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=ClyB_OXYG5c:mIabjZIKPEg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/ClyB_OXYG5c" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74270</feedburner:origLink></item><item><title>DOTmed Business News’ Biomed Symposium</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/QgmjjvKOjdo/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74271</guid><description>&lt;strong&gt;DOTmed Business News’ Biomed Symposium&lt;/strong&gt;&lt;br /&gt;DOTmed Business News a leading health care magazine catering to industry professionals...&lt;br /&gt;DOTmed Business News&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QgmjjvKOjdo:MgGaFIM6_tI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QgmjjvKOjdo:MgGaFIM6_tI:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QgmjjvKOjdo:MgGaFIM6_tI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=QgmjjvKOjdo:MgGaFIM6_tI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/QgmjjvKOjdo" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74271</feedburner:origLink></item><item><title>Ferring to Present Safety Analysis for FIRMAGON® (degarelix) at the American Urological Association Annual Meeting</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/6uQ0nqsAdiA/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74272</guid><description>&lt;strong&gt;Ferring to Present Safety Analysis for FIRMAGON&amp;#174; (degarelix) at the American Urological Association Annual Meeting&lt;/strong&gt;&lt;br /&gt;The f...&lt;br /&gt;Ferring Pharmaceuticals&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6uQ0nqsAdiA:GY6lALNLfUM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6uQ0nqsAdiA:GY6lALNLfUM:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6uQ0nqsAdiA:GY6lALNLfUM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=6uQ0nqsAdiA:GY6lALNLfUM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/6uQ0nqsAdiA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74272</feedburner:origLink></item><item><title>Seaside Therapeutics to Announce Results from a Phase 2b Clinical Trial of Arbaclofen in Autism Spectrum Disorder at the International Meeting for Autism Research (IMFAR) 2013 Conference</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/6SeiSngnqBc/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74273</guid><description>&lt;strong&gt;Seaside Therapeutics to Announce Results from a Phase 2b Clinical Trial of Arbaclofen in Autism Spectrum Disorder at the International Meet...&lt;br /&gt;Seaside Therapeutics&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6SeiSngnqBc:Sqcwda3Guu4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6SeiSngnqBc:Sqcwda3Guu4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6SeiSngnqBc:Sqcwda3Guu4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=6SeiSngnqBc:Sqcwda3Guu4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/6SeiSngnqBc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74273</feedburner:origLink></item><item><title>Genemarkers Proud Sponsor of the Rare Disease Challenge</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/79He7kfquMU/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74274</guid><description>&lt;strong&gt;Genemarkers Proud Sponsor of the Rare Disease Challenge&lt;/strong&gt;&lt;br /&gt;Genemarkers is proud to be a sponsor of the Rare Disease Science Chal...&lt;br /&gt;Genemarkers&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=79He7kfquMU:eB_dTCwDoa4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=79He7kfquMU:eB_dTCwDoa4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=79He7kfquMU:eB_dTCwDoa4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=79He7kfquMU:eB_dTCwDoa4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/79He7kfquMU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74274</feedburner:origLink></item><item><title>PPD’s Reputation Ranked Best of all CROs in CenterWatch’s Global Survey of Clinical Research Sites</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/UhRGMN5-xCI/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74275</guid><description>&lt;strong&gt;PPD’s Reputation Ranked Best of all CROs in CenterWatch’s Global Survey of Clinical Research Sites&lt;/strong&gt;&lt;br /&gt;Pharmaceutical Product Dev...&lt;br /&gt;PPD&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=UhRGMN5-xCI:NF-kf08wIyI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=UhRGMN5-xCI:NF-kf08wIyI:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=UhRGMN5-xCI:NF-kf08wIyI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=UhRGMN5-xCI:NF-kf08wIyI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/UhRGMN5-xCI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74275</feedburner:origLink></item><item><title>Demand for BioCheck Suspicious Powder Screening Tests Surges Following Ricin Scares</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/5-DkIuKIRJo/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74279</guid><description>&lt;strong&gt;Demand for BioCheck Suspicious Powder Screening Tests Surges Following Ricin Scares&lt;/strong&gt;&lt;br /&gt;Two weeks after the first mailings of pow...&lt;br /&gt;20/20 BioResponse&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=5-DkIuKIRJo:Ru5-cKaWtbw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=5-DkIuKIRJo:Ru5-cKaWtbw:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=5-DkIuKIRJo:Ru5-cKaWtbw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=5-DkIuKIRJo:Ru5-cKaWtbw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/5-DkIuKIRJo" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74279</feedburner:origLink></item><item><title>Beware of Prescriptions Not Matching Pill Bottle Contents</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/pxf9b-gMlpA/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74280</guid><description>&lt;strong&gt;Beware of Prescriptions Not Matching Pill Bottle Contents&lt;/strong&gt;&lt;br /&gt;The American Association of Clinical Endocrinologists (AACE) has la...&lt;br /&gt;American Association of Clinical Endocrinologists (AACE)&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=pxf9b-gMlpA:JXoxuY4F6tA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=pxf9b-gMlpA:JXoxuY4F6tA:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=pxf9b-gMlpA:JXoxuY4F6tA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=pxf9b-gMlpA:JXoxuY4F6tA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/pxf9b-gMlpA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74280</feedburner:origLink></item><item><title>Alkermes’ Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/U3TBK-dO18w/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74281</guid><description>&lt;strong&gt;Alkermes’ Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference&lt;/strong&gt;&lt;br /&gt;Alkermes plc (NA...&lt;br /&gt;Alkermes plc&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=U3TBK-dO18w:ofAOb7p4DYE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=U3TBK-dO18w:ofAOb7p4DYE:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=U3TBK-dO18w:ofAOb7p4DYE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=U3TBK-dO18w:ofAOb7p4DYE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/U3TBK-dO18w" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74281</feedburner:origLink></item><item><title>BioForward Testifies in Support of Assembly Bill 181 and Increasing Pool of Capital in Wisconsin</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/ADdhq5SieRs/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74282</guid><description>&lt;strong&gt;BioForward Testifies in Support of Assembly Bill 181 and Increasing Pool of Capital in Wisconsin&lt;/strong&gt;&lt;br /&gt;Today the Assembly Committee...&lt;br /&gt;BioForward&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ADdhq5SieRs:YWmt0hTQanE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ADdhq5SieRs:YWmt0hTQanE:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ADdhq5SieRs:YWmt0hTQanE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=ADdhq5SieRs:YWmt0hTQanE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/ADdhq5SieRs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74282</feedburner:origLink></item><item><title>Anacor Pharmaceuticals Announces Closing of $23 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Over-Allotment Option</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/I1LqDX6ZZCA/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74283</guid><description>&lt;strong&gt;Anacor Pharmaceuticals Announces Closing of $23 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Over-Allo...&lt;br /&gt;Anacor Pharmaceuticals&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=I1LqDX6ZZCA:stYyC8izX-c:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=I1LqDX6ZZCA:stYyC8izX-c:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=I1LqDX6ZZCA:stYyC8izX-c:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=I1LqDX6ZZCA:stYyC8izX-c:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/I1LqDX6ZZCA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74283</feedburner:origLink></item><item><title>St. Jude Medical Announces Second Quarter Dividend</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/vszoOeUgZWA/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74284</guid><description>&lt;strong&gt;St. Jude Medical Announces Second Quarter Dividend&lt;/strong&gt;&lt;br /&gt;St. Jude Medical Inc.&lt;br /&gt;St. Jude Medical Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vszoOeUgZWA:21XzFPHgJ08:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vszoOeUgZWA:21XzFPHgJ08:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vszoOeUgZWA:21XzFPHgJ08:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=vszoOeUgZWA:21XzFPHgJ08:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/vszoOeUgZWA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74284</feedburner:origLink></item><item><title>Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/R1sa8mj8YtE/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74285</guid><description>&lt;strong&gt;Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants&lt;/strong&gt;&lt;br /&gt;Idera Pharmaceuticals (Nasdaq: IDRA) ...&lt;br /&gt;Idera Pharmaceuticals&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=R1sa8mj8YtE:U0Pag1of4SY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=R1sa8mj8YtE:U0Pag1of4SY:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=R1sa8mj8YtE:U0Pag1of4SY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=R1sa8mj8YtE:U0Pag1of4SY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/R1sa8mj8YtE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74285</feedburner:origLink></item><item><title>Sanofi Q1 2013 - Interview with CFO Jérôme Contamine</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/ySi1rhMTiaE/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74286</guid><description>&lt;strong&gt;Sanofi Q1 2013 - Interview with CFO J&amp;#233;r&amp;#244;me Contamine&lt;/strong&gt;&lt;br /&gt;Sanofi a global and diversified healthcare leader reports earn...&lt;br /&gt;Sanofi&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ySi1rhMTiaE:N4vIIqGfSHE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ySi1rhMTiaE:N4vIIqGfSHE:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ySi1rhMTiaE:N4vIIqGfSHE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=ySi1rhMTiaE:N4vIIqGfSHE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/ySi1rhMTiaE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74286</feedburner:origLink></item><item><title>Top Pharmaceutical Companies Bridge the Gap between Portfolio and Lifecycle Management</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/G-NXspP7cJc/pressrel.asp</link><pubDate>Thu, 23 May 2013 18:00:00 PDT</pubDate><guid isPermaLink="false">http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74287</guid><description>&lt;strong&gt;Top Pharmaceutical Companies Bridge the Gap between Portfolio and Lifecycle Management&lt;/strong&gt;&lt;br /&gt;Top-performing drug companies implemen...&lt;br /&gt;Cutting Edge Information&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=G-NXspP7cJc:rvGv3_i9QAc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=G-NXspP7cJc:rvGv3_i9QAc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=G-NXspP7cJc:rvGv3_i9QAc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=G-NXspP7cJc:rvGv3_i9QAc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/G-NXspP7cJc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=74287</feedburner:origLink></item></channel></rss>
